Pain News and Research

Latest Pain News and Research

Multi-year initiative to help people live longer and better

With 10,000 Americans turning 65 every day - and according to new research released today, a majority of them expect to live to nearly 90 - the celebration of older Americans is a developing trend, and more people are aspiring to live longer and better than ever before.

18 Jun 2012

Cancer publishes Aeterna Zentaris' perifosine Phase 2 trials in RCC

Aeterna Zentaris Inc. today announced that data from two Phase 2 trials in renal cell carcinoma (RCC) for the Company's oral anticancer drug, perifosine, have been published in the June 2012 issue of Cancer, a publication of the American Cancer Society.

18 Jun 2012

Updated data from ARIAD’s ponatinib pivotal trial on CML or Ph+ ALL

ARIAD Pharmaceuticals, Inc. today announced updated clinical data from the pivotal PACE trial of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with chronic myeloid leukaemia (CML) or Philadelphia-positive acute lymphoblastic leukaemia (Ph+ ALL), who are resistant or intolerant to dasatinib or nilotinib or who have the T315I mutation.

18 Jun 2012

Researchers identify commensal bacteria in the human intestine

Researchers at Baylor College of Medicine and Texas Children's Hospital have identified commensal bacteria in the human intestine that produce a neurotransmitter that may play a role in preventing or treating inflammatory bowel diseases such as Crohn's disease.

18 Jun 2012

Ginger gum can cure migraine headaches

If you or someone you care about is among the one in 10 Americans who suffer with migraine headaches, recent research may provide some relief.

16 Jun 2012

Stereotactic ablative radiotherapy benefits stage I non-small cell lung cancer patients

Until recently, many elderly patients with stage I non-small cell lung cancer were left untreated because treatment may not improve their quality of life. However, stereotactic ablative radiotherapy (SABR) has become one of the standards of treatment for these patients. The outpatient treatment given over a two-week period allows frail patients to undergo the treatment.

16 Jun 2012

Georgia's estimate Medicaid shortfall is $300 million; Texas' independent pharmacists upset by Medicaid transition

The state's Medicaid agency has a projected $300 million hole to fill in next year's budget. If the shortfall remains at that level, the financial request to the General Assembly in January will be "very high" from a historical perspective, said Vince Harris, chief financial officer of the Department of Community Health, after the agency's board meeting Thursday. The projected $308 million shortfall for fiscal 2013 stems mostly from growth in the program's spending.

16 Jun 2012

Anti-TNFs increase risk for herpes zoster infections in IRD patients

Patients with inflammatory rheumatic diseases who are treated with anti-tumor necrosis factor medications are significantly more likely to experience herpes zoster infections than those treated with traditional disease-modifying anti-rheumatic drugs, study results show.

15 Jun 2012

Pain, appearance improvements satisfy foot and ankle surgery patients

Ongoing pain, appearance, choice of footwear, and impact of pain and function on social interaction are the main predictors for patient satisfaction following foot or ankle surgery, UK research indicates.

15 Jun 2012

Advances in robotic spine surgery

1. Please could you give a brief outline of robotic spine surgery and its recent history? Robotic spine surgery is very new, less than 10 years old. There are only 10 hospitals in the US offering it and we are the second hospital in California to offer this technology.

15 Jun 2012

First Edition: June 15, 2012

Today's headlines include the latest on how the White House and congressional lawmakers are bracing for the Supreme Court's health law decision.

15 Jun 2012

Colorado and Alabama leaders offer different views on health law decision

Colorado's governor says the state will continue to build its insurance exchange and to advance other elements of the health law regardless of the Supreme Court's ruling. Meanwhile, Alabama's attorney general predicts the court will strike down the law.

15 Jun 2012

DFINE completes initial phase of STAR Tumor Ablation System trial

DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced an upcoming poster presentation at the World Congress of Interventional Oncology (WCIO), June 14-18 in Chicago.

15 Jun 2012

Osiris receives consent from NZ to market Prochymal for GvHD

Osiris Therapeutics, Inc., announced today it has received consent from New Zealand to market its first-in-class stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children.

15 Jun 2012

Positive top-line results from Teva’s GALA Phase III trial on RRMS

Teva Pharmaceutical Industries Ltd. today announced positive top-line results from the GALA (Glatiramer Acetate Low-Frequency Administration) Phase III clinical trial assessing the efficacy, safety and tolerability of 40 mg/1 ml glatiramer acetate injection (GA) administered subcutaneously three times a week compared to placebo in relapsing-remitting multiple sclerosis (RRMS) patients.

15 Jun 2012

Third Rock Ventures announces formation of Global Blood Therapeutics

Third Rock Ventures, LLC today announced the formation of Global Blood Therapeutics, Inc. and its $40.7 million Series A financing of the company.

15 Jun 2012

Roundup: Calpers rate hike approved; Painkiller databases slow abuse in Mass., Minn.; Health workers authorize strike in Philly

The California Public Employees' Retirement System, the third-largest purchaser of health benefits in the country, approved a 9.6 percent increase in health premiums next year for its nearly 1.3 million members.

15 Jun 2012

FDA approves GSK’s MenHibrix to treat meningococcal and Hib diseases

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine].

15 Jun 2012

FDA approves Menhibrix for vaccination against meningococcal and Hib diseases

The U.S. Food and Drug Administration today approved Menhibrix, a combination vaccine for infants and children ages 6 weeks through 18 months, for prevention of invasive disease caused by Neisseria meningitidis serogroups C and Yand Haemophilus influenzae type b.

15 Jun 2012

Prior chemotherapy extends postpalliative survival in pancreatic cancer

Patients with locally advanced pancreatic cancer have a more favorable prognosis after palliative chemoradiotherapy if they have previously been treated with a gemcitabine-based therapy, say Danish researchers.

14 Jun 2012